Yahoo Web Search

Search results

    • Q1 2024 Panbela Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 55 minutes ago

      This study is actively enrolling. The Phase II eflornithine trial in type 1 diabetes is a multi-center...adenocarcinoma cell lines regardless of their platinum sensitivity. And we found that ...